Dose-response Effect of Community Dance Programme

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60-85
SponsorNational University of Singapore

About this trial

The goal of this interventional study is to examine the dose-response effect of Community Dance Programme (CDP) on the physical, cognitive and psychological health of pre-frail and mildly frail community-dwelling older adults. The main questions it aims to answer are:

Hypothesis 1: Two sessions of CDP per week (75 minutes each) significantly increase the physical outcomes (i.e. CFS, EFS, SPPB, grip strength) of community-dwelling older adults as compared to one session of CDP per week.

Hypothesis 2: Two sessions of CDP per week significantly improve the cognitive outcomes (i.e. MoCA, SDMT) of community-dwelling older adults as compared to one session of CDP per week.

Hypothesis 3: Two sessions of CDP per week significantly improve the psychosocial outcomes (i.e. WHOQOL-OLD, De Jong Giervald Loneliness Scale, GPIC scale, SHS, SSQ) of community-dwelling older adults as compared to one session of CDP per week.

Intervention: The participants will be asked to attend two sessions of CDP per week for 12 weeks at their respective Active Ageing Centres (AACs).

Active control: The participants will be asked to attend one session of CDP per week for 12 weeks AACs.

* The participants will be asked to go to the AACs at baseline and after 12 weeks of CDP intervention for the collection of data. * The participants will be asked to wear fitness trackers to track their heart rates during the CDP sessions to ensure that the dance curriculum is kept within the moderate intensity.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Aged 60 to 85.

Able to understand and communicate in either English or Mandarin.

Able to give consent to participate.

Able to commit for three months and able to achieve at least an attendance rate of 75% for the dance program.

Disqualifiers

Abbreviated Mental Test (AMT) score of less than 8.

A score of more than 7 on the Edmonton Frail Scale - Acute Care or a score of more than 5 on Clinical Frailty Scale

Diagnosed with severe cognitive or psychiatric disorders.

Have severe hearing or vision impairments

Trial design

Design model

Parallel

Treatments tested in this trial

  • Dance

    Behavioral

    CDP was designed based on a 12-week dance curriculum, which involves 3 separate blocks of choreography of increasing complexity and intensity. According to World Health Organization, a minimum of 150 minutes of moderate intensity exercise would result in improvement in physical health, therefore, the intervention arm would involve 2 sessions of CDP, 75 minutes per session each week.

  • Active Control

    Behavioral

    CDP was designed based on a 12-week dance curriculum, which involves 3 separate blocks of choreography of increasing complexity and intensity. According to World Health Organization, a minimum of 150 minutes of moderate intensity exercise would result in improvement in physical health, therefore, the active control arm would only include 60 minutes of CDP (1 session) per week to assess the effect of CDP on the cognitive and physical health of older adults.

Treatment groups

284 Participants
are divided into 2 treatment groups
Group A: Intervention armExperimental treatment 1 intervention
Group B: Active controlActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Short Physical Performance Battery

Evaluates the physical function. This instrument comprises physical tests of standing balance, gait speed, and chair stand. Each component (i.e., balance, gait speed, chair stand) will be scored from 0 to 4, with a score of 0 indicating inability to carry out the test and a score of 4 indicating perfect execution of the test. The total score ranges from 0 to 12, with higher scores indicating higher physical performance

Time frame
From enrollment to the end of the interventional period at 12 weeks.

Secondary outcomes

1

Clinical Frailty Scale

This is a 9 point-scale which assesses the degree of frailty based on a visual chart which aids trained assessors to evaluate frailty. This scale depends on individual clinical judgement assess if the patient can independently perform tasks such as bathing, dressing, housework, going upstairs, going out alone, going shopping, taking care of finances, taking medications, and preparing meals. The higher the number, the more frail the individual. It is a tool that has been validated and widely used in local clinical and community settings.

Time frame
From enrollment to end of interventional period of 12 weeks
2

Edmonton Frailty Scale - Acute Care

This is an 11-item questionnaire that examines nine domains of frailty (i.e., cognition, general health status, functional independence, social support, medication use, nutrition, mood, continence, and functioning performance). The scores range from 0 to 17, with higher scores indicating higher levels of frailty. The scores can be categorized into five levels of frailty, namely: fit (0-3), vulnerable (4-5), mild frailty (6-7), Moderate frailty (8-9) and severe frailty (≥10). This instrument has been utilised and validated in a local tertiary hospital, with high acceptability and low inter-rater variability

Time frame
From enrollment to end of interventional period of 12 weeks
3

Screening for Oral Frailty Tool

The oral frailty scale comprises 6 items, including number of teeth, difficulty in swallowing, difficulty in chewing, difficulty in articulatory oral motor, dry mouth, and oral pain, and is assessed using a yes or no question. The correlations ranged from 0.40 to 0.66 when correlating each item with the total score of the scale. Using frailty and sarcopenia as criteria, the area under the curve for the SOFT was 0.71. The optimal cutoff for the SOFT was 2,

Time frame
From enrollment to end of interventional period of 12 weeks
4

MOXY (muscle oxygenation)

MOXY (Moxy, Fortiori Design LLC, Minnesota, USA) is a non-invasive small wearable portable device that measures muscle oxygen saturation (SmO2), using near-infrared spectroscopy (NIRS) \[38\]. MOXY measures oxygen levels in the muscles of participants during exercise. Saliva sampling and MOXY oxygen monitoring are non-invasive procedures.

Time frame
From enrollment to the end of the interventional period of 12 weeks.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

National University of Singapore

Lead sponsor

National Medical Research Council (NMRC), Singapore

Collaborator